Statistical analysis of relation between plasma methotrexate concentration and toxicity in high-dose methotrexate therapy of childhood nonHodgkin lymphoma-Reference-Cited by-同舟云学术

Statistical analysis of relation between plasma methotrexate concentration and toxicity in high-dose methotrexate therapy of childhood nonHodgkin lymphoma

Published:2014-10-30 Issue:2 Volume:62 Page:279-284
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Tsurusawa Masahito¹,Gosho Masahiko¹,Mori Tetsuya²,Mitsui Tetsuo³,Sunami Shosuke⁴,Kobayashi Ryoji⁵,Fukano Reiji⁶,Tanaka Fumiko⁷,Fujita Naoto⁸,Inada Hiroko⁹,Koh Katsuyoshi¹⁰,Takimoto Tetsuya¹¹,Saito Akiko¹²,Fujimoto Junichiro¹¹,Nakazawa Atsuko¹³,Horibe Keizo¹²,

Affiliation:

1. The Advanced Medical Research Center; Aichi Medical University; Aichi Japan

2. Division of Pediatric Oncology; National Center for Child Health and Development; Tokyo Japan

3. Department of Pediatrics; Yamagata University Hospital; Yamagata Japan

4. Department of Pediatrics; Japanese Red Cross Narita Hospital; Chiba Japan

5. Department of Pediatrics; Sapporo Hokuyu Hospital; Sapporo Japan

6. Department of Pediatrics; Kushu Cancer Center; Fukuoka Japan

7. Department of Pediatrics; Saiseikai Yokohama Nanbu Hospital; Kanagawa Japan

8. Department of Pediatrics; Hiroshima Red Cross Hospital and Atomic Bomb Survivors Hospital; Hiroshima Japan

9. Department of Pediatrics; Kurume University Hospital; Kurume Japan

10. Department of Hematology-Oncology; Saitama Children's Medical Center; Saitama Japan

11. Clinical Research Center; National Center for Child Health and Development; Tokyo Japan

12. Clinical Research Center; National Hospital Organization Nagoya Medical Center; Nagoya Japan

13. Department of Pathology; National Center for Child Health and Development; Tokyo Japan

Funder

Ministry of Health, Labor and Welfare of Japan

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.25305/fullpdf

Reference27 articles.

1. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: Reports of the Berlin-Frankfurt-Münster Group trial NHL-BFM 90;Reiter;Blood,1999

2. The Société Française d'Oncologie Pédiatrique LMB89 protocol: Highly effective multiagent chemotherapy tailored to the tumor burden and response in 561 unselected children with B-cell lymphomas and L3 leukemia;Patte;Blood,2001

3. Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents. It is possible to reduce treatment for the early responding patients;Patte;Blood,2007

4. Improved treatment results of children with B-cell non-Hodgkin lymphoma: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group B-NHL03 Study;Tsurusawa;Pediatr Blood Cancer,2014

5. Cell kinetics in Burkitt lymphoma;Iversen;Eur J Cancer,1974

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early therapeutic drug monitoring of methotrexate and its association with acute kidney injury: A retrospective cohort study;Cancer Medicine;2024-09

2. Cancer drugs and acute kidney injury: new therapies and new challenges;Current Opinion in Nephrology & Hypertension;2024-05-07

3. Factors influencing delayed high-dose methotrexate excretion and its correlation with adverse reactions after treatment in children with malignant hematological tumors;Translational Pediatrics;2024-02

4. Glucarpidase (carboxypeptidase G2): Biotechnological production, clinical application as a methotrexate antidote, and placement in targeted cancer therapy;Biomedicine & Pharmacotherapy;2023-10

5. Predicting delayed methotrexate elimination in pediatric acute lymphoblastic leukemia patients: an innovative web-based machine learning tool developed through a multicenter, retrospective analysis;BMC Medical Informatics and Decision Making;2023-08-03